Bivalirudin

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 63323-562
  • Package NDC 63323-562-15
  • Application number ANDA090189
  • SPL ID c6dcd639-86b8-40e0-b18b-e2d4393f274b
  • SPL set ID 50975be1-6d1f-497c-b989-1825a0fae1a7
  • UNII TN9BEX005G
  • RxCUI 308769

What the source publishes

Labeler
Fresenius Kabi USA, LLC
Active ingredients
Bivalirudin
Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:63323-562_c6dcd639-86b8-40e0-b18b-e2d4393f274b
{
  "name": "Bivalirudin",
  "splId": "c6dcd639-86b8-40e0-b18b-e2d4393f274b",
  "labels": [
    {
      "setId": "50975be1-6d1f-497c-b989-1825a0fae1a7",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=50975be1-6d1f-497c-b989-1825a0fae1a7",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=50975be1-6d1f-497c-b989-1825a0fae1a7"
    }
  ],
  "routes": [
    "INTRAVENOUS"
  ],
  "labeler": "Fresenius Kabi USA, LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "10 VIAL, SINGLE-USE in 1 CARTON (63323-562-15)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (63323-562-41)",
      "package_ndc": "63323-562-15",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20171030"
    }
  ],
  "productId": "63323-562_c6dcd639-86b8-40e0-b18b-e2d4393f274b",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
  "productNdc": "63323-562",
  "deaSchedule": null,
  "genericName": "Bivalirudin",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "BIVALIRUDIN",
      "strength": "250 mg/1"
    }
  ],
  "applicationNumber": "ANDA090189",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20171030",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175980",
      "N0000175518",
      "N0000009963"
    ],
    "upc": [
      "0363323562410"
    ],
    "unii": [
      "TN9BEX005G"
    ],
    "rxcui": [
      "308769"
    ],
    "spl_set_id": [
      "50975be1-6d1f-497c-b989-1825a0fae1a7"
    ],
    "pharm_class_epc": [
      "Anti-coagulant [EPC]",
      "Direct Thrombin Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "Thrombin Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Fresenius Kabi USA, LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:63323-562_c6dcd639-86b8-40e0-b18b-e2d4393f274b"